Premium
Synergistic Chemotherapy: Bioengineered Dual‐Targeting Protein Nanocage for Stereoscopical Loading of Synergistic Hydrophilic/Hydrophobic Drugs to Enhance Anticancer Efficacy (Adv. Funct. Mater. 29/2021)
Author(s) -
Wang Zhuoran,
Zhang Shuai,
Zhang Ruofei,
Chen Xuehui,
Sun Guoming,
Zhou Meng,
Han Qiubai,
Zhang Baoli,
Zhao Yue,
Jiang Bing,
Yang Yili,
Yan Xiyun,
Fan Kelong
Publication year - 2021
Publication title -
advanced functional materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.069
H-Index - 322
eISSN - 1616-3028
pISSN - 1616-301X
DOI - 10.1002/adfm.202170207
Subject(s) - nanocarriers , nanocages , materials science , drug , drug delivery , amphiphile , nanotechnology , targeted drug delivery , pharmacology , cancer research , chemistry , polymer , medicine , biochemistry , copolymer , catalysis , composite material
In article number 2102004, Xiyun Yan, Kelong Fan, and co‐workers present an amphiphilic multi‐drug loading protein nanocage (Am‐PNCage) with a dual‐tumor targeting (CD71 and Integrin) property, which exhibits a spatiotemporally programmed cascade drug release pattern and kills drug‐resistant tumor cells synergistically. It represents a novel promising protein cage nanocarrier platform for co‐loading synergistic hydrophilic and hydrophobic drug pairs and targeted combination chemotherapy.